Considerations for Treating Corona Virus (Sars-Cov-2) Infection with Passive Immunotherapy
The corona viruses are transient RNA viruses; once an infected individual recovers he or she becomes virus-free and immune. One could expect that in SARS-Covid-19 also, infected individuals who recover will have developed some form of protective immunity. Very little is yet known about its developm...
Main Authors: | Abraham Karpas, Douglas Bainbridge, Stephen Ash |
---|---|
Format: | Article |
Language: | English |
Published: |
Firenze University Press
2020-05-01
|
Series: | Substantia |
Subjects: | |
Online Access: | https://riviste.fupress.net/index.php/subs/article/view/924 |
Similar Items
-
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
by: Shuang Dong, et al.
Published: (2020-08-01) -
Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01) -
SARS-CoV-2 Pandemic: Not the First, Not the Last
by: Paolo Calistri, et al.
Published: (2021-02-01) -
An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment
by: Ramesh Bhandari, et al.
Published: (2020-06-01) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)